Enlivex Therapeutics Ltd • ENLV

Capital at risk.

About Enlivex Therapeutics Ltd
Ticker
info
ENLV
Trading on
info
NASDAQ
ISIN
info
IL0011319527
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
-
Headquarters
info
14 Einstein Street, Ness Ziona, undefined, Israel, 7403618
Employees
info
0
Website
info
enlivex.com
Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra (ENX-CL-02-002), which is in phase II clinical trial for the treatment of organ dysfunction and failure caused by sepsis; and Allocetra (ENX-CL-05-001), which is in phase I/II clinical trial to treat moderate knee osteoarthritis. The company also develops 0189-22-KMC, which is in phase I/II clinical trial to treat end-stage knee osteoarthritis; 0006-24-KMC, which is in phase I/II clinical trial for the treatment of Basal thumb osteoarthritis; and ENX-CL-06-001 to treat Psoriatic arthritis and is in phase I/II clinical trial. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Ness Ziona, Israel.
Metrics
BasicAdvanced
Market cap
info
$229M
P/E ratio
info
-
EPS
info
-$0.54
Dividend Yield
info
0.00%
Beta
info
1.52
Forward P/E ratio
info
0
EBIDTA
info
$-14.3M
Ex dividend date
info
-
Price & volume
Market cap
info
$229M
Average daily volume
info
0.5M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
13.12
Earnings
EPS
info
-$0.54
EPS estimate (current quarter)
info
-$0.12
EPS estimate (next quarter)
info
-$0.13
EBITDA
info
$-14.3M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.52
52-week High
info
$2.10
52-week Low
info
$0.66
50-day moving average
info
$0.93
200-day moving average
info
$1.05
Short ratio
info
0.71
Short %
info
0.26%
Management effectiveness
ROE (TTM)
info
-57.64%
ROA (TTM)
info
-36.02%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
237M
Float
info
17.3M
Insiders %
info
0.46%
Institutions %
info
0.41%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$13.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.23
-$0.16
-43.75%
Q4 • 24Missed
-$0.15
-$0.16
6.25%
Q1 • 25Beat
-$0.11
-$0.15
26.20%
Q2 • 25Beat
-$0.09
-$0.14
37.50%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-1.9M
-∞%
Q2 • 25
$0M
$-2.2M
-∞%
Q3 • 25
NaN%
18.04%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$22.6M
$3.5M
15.68%
Q2 • 25
$20.9M
$3.5M
16.51%
Q3 • 25
-7.35%
-2.45%
5.28%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-1.2M
$1.1M
$0M
$-1.2M
Q2 • 25
$-2.3M
$3.8M
$0.4M
$-2.3M
Q3 • 25
87.22%
256.88%
39,496.88%
92.45%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Enlivex Therapeutics Ltd share?
Collapse

Enlivex Therapeutics Ltd shares are currently traded for undefined per share.

How many shares does Enlivex Therapeutics Ltd have?
Collapse

Enlivex Therapeutics Ltd currently has 237M shares.

Does Enlivex Therapeutics Ltd pay dividends?
Collapse

No, Enlivex Therapeutics Ltd doesn't pay dividends.

What is Enlivex Therapeutics Ltd 52 week high?
Collapse

Enlivex Therapeutics Ltd 52 week high is $2.10.

What is Enlivex Therapeutics Ltd 52 week low?
Collapse

Enlivex Therapeutics Ltd 52 week low is $0.66.

What is the 200-day moving average of Enlivex Therapeutics Ltd?
Collapse

Enlivex Therapeutics Ltd 200-day moving average is $1.05.

Who is Enlivex Therapeutics Ltd CEO?
Collapse

The CEO of Enlivex Therapeutics Ltd is -.

How many employees Enlivex Therapeutics Ltd has?
Collapse

Enlivex Therapeutics Ltd has 0 employees.

What is the market cap of Enlivex Therapeutics Ltd?
Collapse

The market cap of Enlivex Therapeutics Ltd is $229M.

What is the P/E of Enlivex Therapeutics Ltd?
Collapse

The current P/E of Enlivex Therapeutics Ltd is null.

What is the EPS of Enlivex Therapeutics Ltd?
Collapse

The EPS of Enlivex Therapeutics Ltd is -$0.54.

What is the PEG Ratio of Enlivex Therapeutics Ltd?
Collapse

The PEG Ratio of Enlivex Therapeutics Ltd is null.

What do analysts say about Enlivex Therapeutics Ltd?
Collapse

According to the analysts Enlivex Therapeutics Ltd is considered a buy.